March 10, 2026 - 21:00

A Republican senator is taking a stand, refusing to advance a key presidential nomination for the Federal Reserve. Senator Thom Tillis of North Carolina has declared he will not support Kevin Warsh for the position of Federal Reserve Chair until an ongoing criminal investigation into the current chair, Jerome Powell, is fully resolved.
The move creates a significant hurdle for the nomination process, intertwining a prospective appointment with an unresolved probe into the sitting central bank leader. While the specific details and allegations of the investigation into Chair Powell have not been publicly elaborated, the senator's condition underscores the heightened political scrutiny surrounding the nation's most powerful financial institution.
This development injects uncertainty into the leadership of the Fed at a critical time for the economy. The Federal Reserve plays a pivotal role in steering monetary policy, managing inflation, and ensuring financial stability. A delayed or contested confirmation for such a paramount position could lead to prolonged ambiguity regarding the future direction of U.S. economic policy, potentially affecting market confidence. The situation places the administration in a challenging position as it seeks to fill this crucial role.
June 8, 2026 - 23:51
Ballard Spahr’s Consumer Financial Services Group Earns National Recognition Again from Chambers USA in 2026Ballard Spahr`s Consumer Financial Services Group has secured a spot in the 2026 edition of Chambers USA: America`s Leading Lawyers for Business. This marks another year of national recognition for...
June 8, 2026 - 10:49
Enact Holdings Continues To Be The Driver For Genworth FinancialGenworth Financial continues to lean heavily on its majority stake in Enact Holdings, a mortgage insurance provider that now stands as the company`s most valuable asset. With Enact currently valued...
June 7, 2026 - 23:29
Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish OnAclaris Therapeutics Inc. (NASDAQ:ACRS) is drawing renewed attention from Wall Street as a penny stock worth watching. On May 8, analysts at Stifel reiterated a Hold rating on the stock but raised...
June 7, 2026 - 02:36
Weyerhaeuser Co (WY) Stock Outlook: What Happened in Q1?Weyerhaeuser Co (NYSE:WY) has been drawing attention as a strong pick among land and timber stocks. Analysts on the Street are currently forecasting that the company`s share price could climb more...